Goldman Sachs
ACER

Goldman Sachs’s Acer Therapeutics Inc ACER Stock Holding History

Goldman Sachs’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-88,054
Closed -$81.3K – 5984
2023
Q2 		$81.3K Buy
88,054
+69
+0.1% +$61 ﹤0.01% 5394
2023
Q1 		$66.7K Sell
87,985
-13
-0% -$26 ﹤0.01% 5511
2022
Q4 		$221K Hold
87,998
– – ﹤0.01% 5264
2022
Q3 		$122K Sell
87,998
-5,383
-6% -$7.79K ﹤0.01% 5634
2022
Q2 		$118K Sell
93,381
-1,852
-2% -$3.88K ﹤0.01% 5813
2022
Q1 		$276K Sell
95,233
-110
-0.1% -$265 ﹤0.01% 5707
2021
Q4 		$217K Buy
95,343
+1
+0% +$2 ﹤0.01% 5857
2021
Q3 		$244K Hold
95,342
– – ﹤0.01% 5622
2021
Q2 		$273K Hold
95,342
– – ﹤0.01% 5573
2021
Q1 		$297K Hold
95,342
– – ﹤0.01% 5437
2020
Q4 		$250K Buy
95,342
+57,119
+149% +$154K ﹤0.01% 4977
2020
Q3 		$110K Sell
38,223
-2,089
-5% -$6.75K ﹤0.01% 5070
2020
Q2 		$138K Sell
40,312
-7,761
-16% -$21.9K ﹤0.01% 4905
2020
Q1 		$96K Sell
48,073
-2,909
-6% -$10.7K ﹤0.01% 4948
2019
Q4 		$204K Sell
50,982
-51,262
-50% -$174K ﹤0.01% 4888
2019
Q3 		$326K Buy
102,244
+12,040
+13% +$35.3K ﹤0.01% 4648
2019
Q2 		$352K Buy
90,204
+44,518
+97% +$848K ﹤0.01% 4545
2019
Q1 		$1.11M Buy
45,686
+26,482
+138% +$625K ﹤0.01% 4000
2018
Q4 		$386K Buy
+19,204
New +$442K ﹤0.01% 4513
2017
Q1 		– Sell
-5,378
Closed -$52K – 7066
2016
Q4 		$52K Buy
+5,378
New +$94.1K ﹤0.01% 6378
2015
Q1 		– Sell
-360
Closed -$22K – 7342
2014
Q4 		$22K Sell
360
-44
-11% -$3.18K ﹤0.01% 6971
2014
Q3 		$33K Buy
404
+282
+231% +$33.5K ﹤0.01% 6915
2014
Q2 		$17K Sell
122
-91
-43% -$12K ﹤0.01% 6893
2014
Q1 		$33K Buy
213
+7
+3% +$1.06K ﹤0.01% 6635
2013
Q4 		$31K Buy
+206
New +$33.5K ﹤0.01% 6492
2013
Q3 		– Sell
-153
Closed -$19K – 6740
2013
Q2 		$19K Buy
+153
New +$22.3K ﹤0.01% 6193

Other funds holding ACER

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Goldman Sachs's ACER Position: Q3 2023 in Review

Goldman Sachs sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 88,054 shares — an estimated $81.3K sold.

Goldman Sachs first reported a position in ACER in Q2 2013 and held it in 26 quarters. The position peaked at $1.11M in Q1 2019. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Goldman Sachs reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 88,054 Acer Therapeutics Inc shares in Q3 2023, an estimated $81.3K.
  • Goldman Sachs first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 26 quarters.
  • Goldman Sachs's Acer Therapeutics Inc position peaked at $1.11M in Q1 2019.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.